Primary hypothyroidism and quality of life

L Hegedüs, AC Bianco, J Jonklaas… - Nature Reviews …, 2022 - nature.com
In the 1970s, treatment with thyroid extract was superseded by levothyroxine, a synthetic l
form of tetraiodothyronine. Since then, no major innovation has emerged for the treatment of …

Optimal thyroid hormone replacement

J Jonklaas - Endocrine reviews, 2022 - academic.oup.com
Hypothyroidism is a common endocrinopathy, and levothyroxine is frequently prescribed.
Despite the basic tenets of initiating and adjusting levothyroxine being agreed on, there are …

Levothyroxine: conventional and novel drug delivery formulations

H Liu, W Li, W Zhang, S Sun, C Chen - Endocrine reviews, 2023 - academic.oup.com
Although levothyroxine is one of the most prescribed medications in the world, its
bioavailability has been reported to be impaired by many factors, including interfering drugs …

Emerging Therapies in Hypothyroidism

AC Bianco - Annual review of medicine, 2024 - annualreviews.org
Levothyroxine (LT4) is effective for most patients with hypothyroidism. However, a minority of
the patients remain symptomatic despite the normalization of serum thyrotropin levels …

The relevance of T3 in the management of hypothyroidism

D Salvatore, T Porcelli, MD Ettleson… - The Lancet Diabetes & …, 2022 - thelancet.com
Levothyroxine monotherapy has been the standard of care for treatment of hypothyroidism
for more than 40 years. However, patients treated with levothyroxine have relatively lower …

[HTML][HTML] LT4/LT3 combination therapy vs. monotherapy with LT4 for persistent symptoms of hypothyroidism: A systematic review

H Vargas-Uricoechea, L Wartofsky - International Journal of Molecular …, 2024 - mdpi.com
Regardless of the cause, hypothyroidism should be treated with levothyroxine. The
objectives of management are the normalization of TSH levels and the relief of symptoms. In …

Optimizing the treatment of hypothyroidism

AC Bianco, PN Taylor - Nature Reviews Endocrinology, 2024 - nature.com
Daily levothyroxine (LT4) is the standard of care for the treatment of hypothyroidism;
however, a small number of patients experience residual symptoms of hypothyroidism …

Are we restoring thyroid hormone signaling in levothyroxine-treated patients with residual symptoms of hypothyroidism?

S Casula, MD Ettleson, AC Bianco - Endocrine Practice, 2023 - Elsevier
Introduction Levothyroxine (LT4) at doses that maintain the serum thyroid-stimulating
hormone levels within the normal range constitutes the standard of care for the treatment of …

Designing a combined liothyronine (LT3), L-thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4-the importance of patient selection, choice of LT3 and trial …

LD Premawardhana, PN Taylor… - Frontiers in …, 2023 - frontiersin.org
Approximately 10%–15% of subjects with hypothyroidism on L-thyroxine (LT4) alone have
persistent symptoms affecting their quality of life (QoL). Although the cause is unclear, there …

Year in Thyroidology: Clinical Science (2021–2022)

AM Leung - Thyroid, 2023 - liebertpub.com
From my lens through serving the American Thyroid As-sociation (ATA) in several roles, I
have framed this opportunity to highlight select studies published between October 2021 …